Posted inBiotechnology
Sarcopenia: The Future of Muscle Ultrasound?
The relentless march of aging carries with it a plethora of challenges, chief among them being sarcopenia, a condition characterized…
Posted inBiotechnology
Serum Phosphate Levels Link to Hospital Stay in Neonatal Sepsis
A recent study published in BMC Pediatrics has shed light on a crucial aspect of neonatal care that may have…
Posted inBiotechnology
Zenas’ autoimmune drug prompts 95% reduction in new brain lesions in phase 2 MS study
Zenas Biopharma’s autoimmune drug candidate has been tied to a 95% reduction in a type of brain lesions over 12…
Posted inBiotechnology
Exploring Cathepsin Z’s Role in Prostate Cancer
Recent studies have illuminated the multifaceted role of cathepsin Z in prostate cancer, a topic that has sparked intense discussion…
Posted inBiotechnology
Revealing Hyper-Maturity and Rapid Aging in the Hippocampus
In a groundbreaking revelation poised to reshape our understanding of neuropsychiatric disorders, researchers at Fujita Health University and the Tokyo…
Posted inBiotechnology
Teamwork Triumphs: Patient Safety in COVID-19 Care
In a groundbreaking new study, researchers have delved into the complex experiences of healthcare staff at a Swedish university hospital…
Posted inBiotechnology
ABCD2 Enhances Carotid Stenosis Diagnosis with CT Angiography
The integration of advanced imaging technology and clinical risk assessment tools has the potential to revolutionize the detection and management…
Posted inBiotechnology
Dipeptide’s Impact on Ionic Liquid Micellization Explored
Recent research has illuminated the significant role that dipeptides play in the micellization properties of various surface-active ionic liquids, an…
Posted inBiotechnology
Fluid Strategies in Preterm Infants with PDA
In the delicate realm of neonatal care, a groundbreaking study is shedding new light on the management of preterm infants…
Posted inBiotechnology
MapLight goes public via $250M IPO to fund Cobenfy competitor
MapLight Therapeutics is heading to the Nasdaq this morning via a $250 million IPO the biotech will use to advance…